Skip to main content
. 2022 Apr 3;14(4):783. doi: 10.3390/pharmaceutics14040783

Table 3.

Statistical summary of the applied model of 33-BBD on R1 (PS), R2 (%EE), and R3 (%CDR).

Model R2 Adjusted R2 Predicted R2 SD Desirability Remark
Response (R1; PS in nm)
Linear 0.9486 0.9345 0.9293 5.74
2F1 0.9495 0.9137 0.8972 6.67
Quadratic 0.9993 0.9980 0.9911 1.01 0.95 Suggested
Response (R2; EE in %)
Linear 0.7301 0.6565 0.5977 4.42
2F1 0.7645 0.5878 0.4842 4.85
Quadratic 0.9958 0.9881 0.9350 0.8223 0.83 Suggested
Response (R3; CDR in %)
Linear 0.9895 0.9866 0.9798 0.7632
2F1 0.9947 0.9907 0.9815 0.6356
Quadratic 0.9990 0.9972 0.9860 0.3483 0.88 Suggested
HHS Vulnerability Disclosure